loading

Finanzdaten der Bristol Myers Squibb Co-Aktie (BMY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
3.38%
11,865.00
11,477.00 10,966.00 11,226.00 11,337.00
Cost Of Revenue
6.81%
2,932.00
2,745.00 2,506.00 2,876.00 2,566.00
Gross Profit
2.30%
8,933.00
8,732.00 8,460.00 8,350.00 8,771.00
Operating Expenses
189.73%
20,449.00
7,058.00 6,323.00 6,491.00 6,001.00
Interest Income/Expense
34.49%
425.00
316.00 280.00 282.00 288.00
Benefits Costs and Expenses
138.51%
23,381.00
9,803.00 8,829.00 9,367.00 8,567.00
Costs And Expenses
138.51%
23,381.00
9,803.00 8,829.00 9,367.00 8,567.00
Operating Income/Loss
787.93%
-11,516.00
1,674.00 2,137.00 1,859.00 2,770.00
Income/Loss Before Equity Method Investments
772.66%
-11,516.00
1,712.00 2,137.00 1,870.00 2,790.00
Income/Loss From Equity Method Investments
224.00%
31.00
-25.00 18.00 -11.00 -20.00
Income/Loss From Continuing Operations Before Tax
787.93%
-11,516.00
1,674.00 2,137.00 1,859.00 2,770.00
Income Tax Expense/Benefit, Deferred
46.42%
-711.00
-1,327.00 -327.00 -1,086.00 -548.00
Income Tax Expense/Benefit
545.45%
392.00
-88.00 203.00 -218.00 503.00
Income/Loss From Continuing Operations After Tax
775.82%
-11,908.00
1,762.00 1,934.00 2,077.00 2,267.00
Net Income/Loss
775.82%
-11,908.00
1,762.00 1,934.00 2,077.00 2,267.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
3.00
- 6.00 4.00 5.00
Basic Average Shares
14,550%
2,023.00
-14.00 2,057.00 2,093.00 2,099.00
Diluted Average Shares
13,587%
2,023.00
-15.00 2,064.00 2,102.00 2,113.00
Basic Earnings Per Share
777.01%
-5.89
0.87 0.94 0.99 1.08
Diluted Earnings Per Share
777.01%
-5.89
0.87 0.93 0.99 1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general SNY
$48.28
price up icon 0.63%
drug_manufacturers_general PFE
$25.65
price up icon 2.07%
$294.53
price up icon 1.60%
drug_manufacturers_general NVS
$104.28
price up icon 0.41%
drug_manufacturers_general MRK
$99.18
price down icon 0.68%
Kapitalisierung:     |  Volumen (24h):